Gilead live chart

Mga Pangunahing Kaalaman sa Instrumento

Weekly Search
Weekly
Daily
Petsa Isarado Pagbabago Change (%) Buksan High Low

Mga pinakabagong balita

Frances Wang 2024 Dec 29, 16:00

Stock market today: Most Asian stocks fell after US equities declined

Stocks
Frances Wang 2024 Dec 29, 16:00

MicroStrategy joins Nasdaq-100 index: MSTR stock performance analysis 2024

Cryptocurrencies Stocks
Dyogenes Diniz 2024 Dec 29, 16:00

Morning Note: Key Levels & Data Driving the Last Monday of 2024

Forex Morning Note USD
Closing 2024
Dyogenes Diniz 2024 Dec 26, 17:00

Week ahead: Closing 2024 and First Economic data from 2025

Forex Indices
Tesla soars
Dyogenes Diniz 2024 Dec 26, 17:00

Morning Note: Tesla Soars, AUDUSD Hits Key Support, Oil & SP500 Insights

Forex Oil S&P 500
Frances Wang 2024 Dec 26, 16:00

Nikkei 225 up 1.39%: Japanese Stocks Rise Following Yen's Continued Weakness

Stocks
Frances Wang 2024 Dec 25, 16:00

Asian stock market today: most Asian stocks rise amid thin holiday trading

Stocks
Frances Wang 2024 Dec 25, 16:00

Stock market today: Nasdaq, S&P 500, Dow surge ahead of Christmas break

Stocks

Info

Spread

0.63

Spread (%)

0.6240 %

Leverage

1:10

Interes sa Magdamagang Pagbili

-0.0597 %

Interes sa Magdamagang Pagtinda

-0.0292 %

Currency

USD

Trading Hours

Oras ng Pagsasara

Biyernes

13:31 - 19:59

Lunes

13:31-19:59

Martes

13:31-19:59

Miyerkules

13:31-19:59

Huwebes

13:31-19:59

Analys och statistik

Buksan

---

Nakaraang Pagsara

---

52 Linggo Mataas/Mababa

--- – ---

Market Cap

129188265984

Natitirang Pagbabahagi

1246630016

Petsa ng Mga Kita (Susunod)

2013-01-28

Pambayad si dividend

2025-03-28

Araw ng Pag-alis ng Karapatan sa Dividend

2025-03-14

Inaasahang Taunang Rate ng Dividend

3.16

Inaasahang Taunang Dividend Yield

0.0295

EPS

0.38

Alamin ang Higit Pa Tungkol sa Instrumentong ito

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Mga kaugnay na instrumento

view_all_instruments
Trustpilot
SettingsRequest history38.1.18PHP Version25.28msRequest Duration2MBMemory UsageGET csrf
status
200 OK
full_url
https://web-qa.staging.markets.com/csrf
controller_action
Closure
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/csrf
action_name
controller_action
Closure
uri
GET csrf
file
routes/web.php:26-30
middleware
web
duration
25.79ms
peak_memory
4MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
0 of 0
array:14 [ "cookie" => array:1 [ 0 => "mktv4_ip_override=ph; mktloc=eyJpdiI6Ijh6M2tDK2hMUDZ2Wk8wc0VxaEFYZUE9PSIsInZhbHVlIjoicHJVNWdGN0FNVGplb3llWmV0RFZZWStYc0VlVHczSzRZM1hpNkZZQjlFT3ZXcmNlcWFPMkdvSWRLM0NFdzNRSSIsIm1hYyI6IjAwY2VlYzdmNjYxZWRlZjE1YWRlODEwZDU0NDc4NTE3YTAyNWU1MTdlYzVmYjYwNDNkNDg2ZTljNmI1N2YxM2EiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Ffr%252Finstrument%252Feurnzd%252F; intent_instrument=eurnzd; XSRF-TOKEN=eyJpdiI6ImZ6UVEyL3B1TWtRUnFGdEtldVV5YkE9PSIsInZhbHVlIjoiTndtcllrNTRZc2ZkSW1IYkczU3JpUDJrY0FYT2I0RXh1OGVPR0NCRlhmcHh4VkVuM1ZFelJGblNXd3pNZlFMOGFla1lnMFI3OUppQURoTjNVWjhUZ2grbG1JbXl3MTBRc3krTnc1ckNiRXZseDA2WDYxSXh5clFNS0VzdGZUcjEiLCJtYWMiOiJiNDlmOWExYWJjZDg0NzM4MWNkNTFmNjkzN2RjNGViNzJmMDkyMmM2MGQzOWU1MzBjYmNlNDE2NTc1OTQ4MzI0IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6Im1jUUdieDlHY1dkR3AvaUtwWFBpblE9PSIsInZhbHVlIjoidjlXUEdBZmx1aVhLb1FoOHhuVGpQUkIrcnFMaHRUemtsbmpOK1RJOUVYNmx4eFJGbldXbVFXUTNUWEpMUUJnVTNiaXlKaE5BNWgrN2cvRjR3MTdBak1obEJjU3k5UFptRDNwdDl5aVZHelp5TGdxc1gvemRTSHMzOExuVm1Vd2MiLCJtYWMiOiIxMjMxYzgxZTM5OTg2MTNkNDkyMmZkMjAwMDE0N2QwMWNlZDljNGNiNjYwOGMyZDAzZTk0N2VmZGU4NzI1MjhhIiwidGFnIjoiIn0%3Dmktv4_ip_override=ph; mktloc=eyJpdiI6Ijh6M2tDK2hMUDZ2Wk8wc0VxaEFYZUE9PSIsInZhbHVlIjoicHJVNWdGN0FNVGplb3llWmV0RFZZWStYc0VlVHczSzRZM1hpNkZZQjlFT3ZXcmNlcWFPMkdvSWR" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate, br, zstd" ] "sec-fetch-dest" => array:1 [ 0 => "empty" ] "sec-fetch-mode" => array:1 [ 0 => "cors" ] "sec-fetch-site" => array:1 [ 0 => "same-origin" ] "accept" => array:1 [ 0 => "*/*" ] "sec-ch-ua-mobile" => array:1 [ 0 => "?0" ] "sec-ch-ua" => array:1 [ 0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129"" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "sec-ch-ua-platform" => array:1 [ 0 => ""Windows"" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "web-qa.staging.markets.com" ] ]
request_cookies
0 of 0
array:6 [ "mktv4_ip_override" => null "mktloc" => "us,us" "intent_group" => null "intent_instrument" => null "XSRF-TOKEN" => "z3KRW3fH3TB6soKoHwqUwYgZpupQLW6goAPXA2ff" "laravel_session" => "ll6B9Hjls6mE0liCNb0L2w3geNm7peUDcz7vTrzA" ]
response_headers
0 of 0
array:3 [ "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Sun, 13 Apr 2025 04:19:36 GMT" ] "content-type" => array:1 [ 0 => "application/json" ] ]
session_attributes
0 of 0
array:4 [ "_token" => "z3KRW3fH3TB6soKoHwqUwYgZpupQLW6goAPXA2ff" "PHPDEBUGBAR_STACK_DATA" => [] "_previous" => array:1 [ "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/fr/EUR/NZD:XX?scheme=light" ] "_flash" => array:2 [ "old" => [] "new" => [] ] ]
    • Booting (23.17ms)time
    • Application (2.08ms)time
    • Routing (442μs)
    • 1 x Booting (91.67%)
      23.17ms
      1 x Application (8.24%)
      2.08ms
      1 x Routing (1.75%)
      442μs
      0 templates were rendered
        uri
        GET csrf
        middleware
        web
        uses
        Closure(Request $request) {#347 class: "Illuminate\Routing\RouteFileRegistrar" this: Illuminate\Routing\RouteFileRegistrar {#344 …} file: "/var/www/website/qa/laravel/routes/web.php" line: "26 to 30" }
        file
        routes/web.php:26-30
        0 statements were executed0μs
              _token
              z3KRW3fH3TB6soKoHwqUwYgZpupQLW6goAPXA2ff
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/fr/EUR/NZD:XX?sch...
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-13 04:19:34GET/ph/instrument/gilead/1870
              #22025-04-13 04:19:36GET/params/ (ajax)
              #32025-04-13 04:19:36GET/csrf/ (ajax)